The global market for Artificial Organs is estimated at US$26.0 Billion in 2023 and is projected to reach US$43.2 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the artificial organs market is driven by several factors, including technological innovations that enhance the effectiveness and safety of these devices. The rising prevalence of chronic diseases that lead to organ failure, such as diabetes and heart disease, is increasing the demand for artificial organs worldwide. Aging populations in developed countries also contribute to this demand, as older age groups are more likely to suffer from conditions requiring organ replacement. Additionally, improvements in healthcare infrastructure and increased healthcare spending globally make these advanced treatments more accessible to a broader audience.
Economic development in emerging markets further expands the reach of the artificial organs market, providing new opportunities for adoption. Lastly, the ongoing challenges in donor organ availability continue to push the need for alternative solutions, bolstering the growth of the artificial organs industry as it works to meet the critical needs of patients worldwide.
The growth in the artificial organs market is driven by several factors, including technological innovations that enhance the effectiveness and safety of these devices. The rising prevalence of chronic diseases that lead to organ failure, such as diabetes and heart disease, is increasing the demand for artificial organs worldwide. Aging populations in developed countries also contribute to this demand, as older age groups are more likely to suffer from conditions requiring organ replacement. Additionally, improvements in healthcare infrastructure and increased healthcare spending globally make these advanced treatments more accessible to a broader audience.
Economic development in emerging markets further expands the reach of the artificial organs market, providing new opportunities for adoption. Lastly, the ongoing challenges in donor organ availability continue to push the need for alternative solutions, bolstering the growth of the artificial organs industry as it works to meet the critical needs of patients worldwide.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Artificial Kidneys segment, which is expected to reach US$23.1 Billion by 2030 with a CAGR of a 8.1%. The Artificial Pancreas segment is also set to grow at 7.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $6.9 Billion in 2023, and China, forecasted to grow at an impressive 7.0% CAGR to reach $6.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Artificial Organs Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Artificial Organs Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Artificial Organs Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, Abiomed Inc., Asahi Kasei Medical Co., Ltd., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 71 Featured):
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Medical Co., Ltd.
- Baxter International Inc.
- F.Hoffmann-La Roche Ltd.
- Fresenius Medical Care AG & Co. KGaA
- HeartWare International Inc.
- Jarvik Heart Inc.
- Medtronic Inc.
- Nikkiso Co. Ltd.
- Nipro Corp.
- SynCardia Systems LLC
- Toray Medical Co., Ltd.
- Xenios AG
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned
- Abbott Laboratories
- Abiomed Inc.
- Asahi Kasei Medical Co., Ltd.
- Baxter International Inc.
- F.Hoffmann-La Roche Ltd.
- Fresenius Medical Care AG & Co. KGaA
- HeartWare International Inc.
- Jarvik Heart Inc.
- Medtronic Inc.
- Nikkiso Co. Ltd.
- Nipro Corp.
- SynCardia Systems LLC
- Toray Medical Co., Ltd.
- Xenios AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 288 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 26 Billion |
| Forecasted Market Value ( USD | $ 43.2 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
